PKM and hepatocellular carcinoma: As hypoxic cells produce nitroreductase (NTR) at a level 100-1000-fold greater than that in normoxic cells, which could reduce azo-containing drugs available for conditional release 26-28, and enable the azo-linked PEGylated anti-PKM2 Ab selectively targets hypoxic HCC cells.